RedHill Biopharma Ltd 20-F for FY2021
RedHill Biopharma Ltd. (RDHL)
20-F
2022-03-17
For: 2021-12-31
View Original
Added on
April 07, 2026
About this 20-F
RedHill Biopharma Ltd filed this 20-F on March 17, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $85.76M
- up 33.2% from $64.36M a year earlier
- Net loss
- $97.74M
- compared with a net loss of $76.17M a year earlier
- Diluted EPS
- -$0.21
- compared with -$0.21 a year earlier